Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Operating Expenses | 4,430 | 7,471 | 5,379 | 4,194 | 4,890 |
| Operating Income | -4,430 | -7,471 | -5,379 | -4,194 | -4,890 |
| Other Income | 970 | 1,028 | 844 | -811 | 2,150 |
| Pre-tax Income | -3,460 | -6,443 | -4,536 | -5,005 | -2,740 |
| Net Income Continuous | -3,453 | -6,443 | -4,536 | -5,005 | -2,720 |
| Net Income | $-3,453 | $-6,443 | $-4,536 | $-5,005 | $-2,720 |
| EPS Basic Total Ops | -0.03 | -0.06 | -0.04 | -0.05 | -0.02 |
| EPS Basic Continuous Ops | -0.03 | -0.06 | -0.04 | -0.05 | -0.03 |
| EPS Diluted Total Ops | -0.03 | -0.06 | -0.04 | -0.05 | -0.02 |
| EPS Diluted Continuous Ops | -0.03 | -0.06 | -0.04 | -0.05 | -0.03 |
| EBITDA(a) | $-4,269 | $-7,301 | $-5,209 | $-4,024 | $-4,730 |